Search results
High-tech sleep products come of age in China
China Daily· 1 hour agoLi said insomnia has been giving her sleepless nights of late. As many as 510 million individuals experience sleep disorders, significantly affecting their quality of life and work, according ...
Russia, China, Iran and North Korea ratcheting up threats against US, what we need to know
Fox News· 2 days agoNEWYou can now listen to Fox News articles! During the next year and beyond, the United States will...
China is trying to solve school bullying, but is it ready to face the causes?
South China Morning Post· 4 days agoIn the eyes of some, the problem may have stemmed from familiar challenges in China. Psychiatrists...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 4 days agoLive from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety PR Newswire SUZHOU, < ...
What to watch on Netflix, Disney+, Prime Video, Apple TV+ and more: New TV shows and movies in June
Yahoo News Canada· 6 days agoIn June Bridgerton Season 3, Part 2 is on Netflix, The Bear Season 3 is on Disney+, I Am: Celine...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 21 hours agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Visual story: a look back at South China Morning Post’s 120 years of history
South China Morning Post· 6 days agoThe South China Morning Post has been a barometer of daily life in Hong Kong since it was founded...
Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
Valley City Times Record· 7 days agoOn June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for...
Paris Olympics: What to know and who to watch during the swimming competition
Associated Press· 18 hours agoA roadmap to follow for swimming during the Paris Olympics.
...Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological Malignancies...
Benzinga· 1 day agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin